These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 10593044)
1. [Meningococcal infections: aspects of microbiology, epidemiology and prevention]. Ehrhard I; Sonntag HG Gesundheitswesen; 1999 Oct; 61 Spec No 1():S41-5. PubMed ID: 10593044 [TBL] [Abstract][Full Text] [Related]
2. Changing epidemiology of meningococcal invasive disease in the Czech republic caused by new clone Neisseria meningitidis C:2a:P1.2(P1.5), ET-15/37. Krizova P; Musilek M Cent Eur J Public Health; 1995 Nov; 3(4):189-94. PubMed ID: 8903519 [TBL] [Abstract][Full Text] [Related]
3. Association of meningococcal phenotypes and genotypes with clinical characteristics and mortality of meningitis in children. Levy C; Taha MK; Weil Olivier C; Quinet B; Lecuyer A; Alonso JM; Aujard Y; Bingen E; Cohen R; Pediatr Infect Dis J; 2010 Jul; 29(7):618-23. PubMed ID: 20168263 [TBL] [Abstract][Full Text] [Related]
4. Prevention of meningococcal disease. Kimmel SR Am Fam Physician; 2005 Nov; 72(10):2049-56. PubMed ID: 16342836 [TBL] [Abstract][Full Text] [Related]
5. The epidemiology of meningococcal disease and the impact of vaccines. Khatami A; Pollard AJ Expert Rev Vaccines; 2010 Mar; 9(3):285-98. PubMed ID: 20218857 [TBL] [Abstract][Full Text] [Related]
6. [Evolution of meningococcal infection among infant population in the autonomous community of Valencia (1996-2000). Effectiveness of A+C meningococcal vaccination]. Goicoechea Sáez M; Fullana Montoro AM; Momparler Carrasco P; Redondo Gallego MJ; Brines Solanes J; Bueno Cañigral FJ Rev Esp Salud Publica; 2003; 77(1):125-42. PubMed ID: 12696392 [TBL] [Abstract][Full Text] [Related]
7. [Surveillance of Neisseria meningitidis in Argentina, 1993-2005: distribution of serogroups, serotypes and serosubtypes isolated from invasive disease]. Chiávetta L; Chávez E; Ruzic A; Mollerach M; Regueira M Rev Argent Microbiol; 2007; 39(1):21-7. PubMed ID: 17585655 [TBL] [Abstract][Full Text] [Related]
8. Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa. von Gottberg A; du Plessis M; Cohen C; Prentice E; Schrag S; de Gouveia L; Coulson G; de Jong G; Klugman K; Clin Infect Dis; 2008 Feb; 46(3):377-86. PubMed ID: 18181736 [TBL] [Abstract][Full Text] [Related]
9. Epidemiology of meningococcal disease in southern Brazil from 1995 to 2003, and molecular characterization of Neisseria meningitidis using multilocus sequence typing. Baethgen LF; Weidlich L; Moraes C; Klein C; Nunes LS; Cafrune PI; Lemos AP; Rios SS; Abreu MF; Kmetzsch C; Sperb AF; Riley LW; Rossetti ML; Zaha A Trop Med Int Health; 2008 Jan; 13(1):31-40. PubMed ID: 18290999 [TBL] [Abstract][Full Text] [Related]
10. [Meningococcal disease 1987-1989. Outbreak of serogroup B:15:P1.16 in the county of Frederiksborg]. Ege PP; Samuelsson SI; Lind I Ugeskr Laeger; 1993 Oct; 155(43):3456-9. PubMed ID: 8256335 [TBL] [Abstract][Full Text] [Related]
13. Hajj-associated outbreak strain of Neisseria meningitidis serogroup W135: estimates of the attack rate in a defined population and the risk of invasive disease developing in carriers. Wilder-Smith A; Goh KT; Barkham T; Paton NI Clin Infect Dis; 2003 Mar; 36(6):679-83. PubMed ID: 12627350 [TBL] [Abstract][Full Text] [Related]
14. Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger. Boisier P; Nicolas P; Djibo S; Taha MK; Jeanne I; Maïnassara HB; Tenebray B; Kairo KK; Giorgini D; Chanteau S Clin Infect Dis; 2007 Mar; 44(5):657-63. PubMed ID: 17278055 [TBL] [Abstract][Full Text] [Related]
15. Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease. Cohn AC; MacNeil JR; Harrison LH; Hatcher C; Theodore J; Schmidt M; Pondo T; Arnold KE; Baumbach J; Bennett N; Craig AS; Farley M; Gershman K; Petit S; Lynfield R; Reingold A; Schaffner W; Shutt KA; Zell ER; Mayer LW; Clark T; Stephens D; Messonnier NE Clin Infect Dis; 2010 Jan; 50(2):184-91. PubMed ID: 20001736 [TBL] [Abstract][Full Text] [Related]
16. A serogroup A meningococcal polysaccharide vaccine: studies in the Sudan to combat cerebrospinal meningitis caused by Neisseria meningitidis group A. Erwa HH; Haseeb MA; Idris AA; Lapeyssonnie L; Sanborn WR; Sippel JE Bull World Health Organ; 1973; 49(3):301-5. PubMed ID: 4211056 [TBL] [Abstract][Full Text] [Related]
17. Prevention of meningococcal disease: current use of polysaccharide and conjugate vaccines. Poland GA Clin Infect Dis; 2010 Mar; 50 Suppl 2():S45-53. PubMed ID: 20144016 [TBL] [Abstract][Full Text] [Related]
18. Annual report of the Australian Meningococcal Surveillance Programme 1996. Commun Dis Intell; 1997 Aug; 21(16):217-21. PubMed ID: 9270181 [TBL] [Abstract][Full Text] [Related]
20. [Clinical and epidemiologic study of meningococcal meningitis in the health region of Santiago de Compostela (1990-1997)]. Juncal AR; Pérez del Molino ML; Rodríguez I; Cid A; Guillán B; Pardo F Enferm Infecc Microbiol Clin; 1997 Dec; 15(10):510-4. PubMed ID: 9522514 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]